SAP R/3 release change: Change, project and revalidation - Prerequisites of a 21 CFR Part 11 implementation

被引:0
|
作者
Metzger, T [1 ]
机构
[1] Aventis Pharma Deutschland GmbH, Qual Operat Drug Prod, EQM, D-65926 Frankfurt, Germany
来源
PHARMAZEUTISCHE INDUSTRIE | 2004年 / 66卷 / 03期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A release change is a challenge for the validation of every existing SAP system, as it is both an IT and revalidation project. The following article provides an integrated approach. It enables the project team in an early stage to consider the needs of computerized systems validation in the same way as technical aspects. It focuses on the view of validation. At the same time, it provides simple means (validation task force, playground system, screenplay) to enable all involved key players to follow a structured approach. Besides, the influence of regulatory demands like Part I I on the project work and different possible solutions to reach compliance is discussed. Finally, the influences of a release change on the general documentation and validation strategy as a chance to reach a higher degree of compliance is discussed.
引用
收藏
页码:337 / 343
页数:7
相关论文
共 9 条